Genetic Immunity, InPlay: Company Completes Patient Enrollment in …SYS-CON Media (press release)… CEO of Genetic Immunity. This novel plasmid DNA-based nanomedicine vaccine candidate, DermaVir Patch, has been under development in the last ten years. …and more »
Original post by dna genetic – Google News and software by Elliott Back